TD Private Client Wealth LLC Has $4.90 Million Stock Holdings in Sanofi $SNY

Posted by Francis Steltz on May 19th, 2026

TD Private Client Wealth LLC trimmed its position in Sanofi (NASDAQ:SNY – Free Report) by 15.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 101,009 shares of the company’s stock after selling 19,138 shares during the period. TD Private Client Wealth LLC’s holdings in Sanofi were worth $4,895,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of SNY. Flagship Harbor Advisors LLC acquired a new stake in shares of Sanofi in the 4th quarter valued at approximately $25,000. Measured Wealth Private Client Group LLC acquired a new stake in Sanofi during the 3rd quarter worth approximately $29,000. Palisade Asset Management LLC acquired a new stake in Sanofi during the 3rd quarter worth approximately $30,000. Sittner & Nelson LLC acquired a new stake in Sanofi during the 3rd quarter worth approximately $47,000. Finally, Costello Asset Management INC raised its holdings in Sanofi by 1,300.0% during the 3rd quarter. Costello Asset Management INC now owns 1,400 shares of the company’s stock worth $66,000 after buying an additional 1,300 shares during the period. 14.03% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Stock Up 2.0%

SNY opened at $43.54 on Tuesday. Sanofi has a fifty-two week low of $42.33 and a fifty-two week high of $53.36. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01. The company has a market capitalization of $106.19 billion, a P/E ratio of 12.16, a P/E/G ratio of 1.05 and a beta of 0.35. The stock has a fifty day moving average of $45.57 and a 200-day moving average of $47.38.

Sanofi Increases Dividend

The business also recently declared an annual dividend, which will be paid on Wednesday, June 3rd. Investors of record on Monday, May 4th will be paid a $2.4225 dividend. This represents a yield of 559.0%. This is a boost from Sanofi’s previous annual dividend of $2.04. The ex-dividend date of this dividend is Monday, May 4th. Sanofi’s payout ratio is presently 49.44%.

Analyst Ratings Changes

Several analysts have commented on SNY shares. BNP Paribas Exane downgraded shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 target price on the stock. in a report on Monday, April 20th. Weiss Ratings upgraded shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 13th. Bank of America downgraded shares of Sanofi from a “buy” rating to a “neutral” rating in a report on Thursday, February 12th. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, March 19th. Finally, Morgan Stanley set a $52.00 price target on shares of Sanofi in a research note on Friday, May 1st. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $51.00.

View Our Latest Research Report on SNY

Sanofi Company Profile

(Free Report)

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.